|GILD||GILEAD SCIENCES INC||5.27%|
|LLY||ELI LILLY CORP||5.13%|
|TMO||THERMO FISHER SCIENTIFIC INC||4.83%|
|JNJ||JOHNSON & JOHNSON||4.40%|
|ALXN||ALEXION PHARMACEUTICALS INC||4.37%|
|UNH||UNITEDHEALTH GROUP INC||4.36%|
|FATE||FATE THERAPEUTICS INC||4.04%|
|BMY||BRISTOL MYERS SQUIBB CO||3.92%|
|EW||EDWARDS LIFESCIENCES CORP||3.86%|
|MRK||MERCK & CO. NEW||3.74%|
|BDX||BECTON DICKINSON & CO||3.53%|
|CVS||CVS HEALTH CORPORATION||3.34%|
|CI||CIGNA CORP NEW||3.29%|
|HZNP||HORIZON THERAPEUTICS PLC||2.84%|
|TNDM||TANDEM DIABETES CARE INC||2.53%|
|BPMC||BLUEPRINT MEDICINES CORPORATION||2.07%|
|BMRN||BIOMARIN PHARAMCEUTICAL INC||1.63%|
|EHC||ENCOMPASS HEALTH CORP NPV||1.41%|
|VAR||VARIAN MEDICAL SYSTEMS INC||1.29%|
|LH||LABORATORY CORP OF AMERICA||1.16%|
|CMD||CANTEL MEDICAL CORP||1.06%|
|EXAS||EXACT SCIENCES CORP||0.98%|
|ZBH||ZIMMER BIOMET HOLDINGS INC||0.94%|
|JAZZ||JAZZ PHARMACEUTICALS PLC||0.87%|
|UHS||UNIVL HEALTH SVS-CLASS B||0.79%|
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Partners Europe Limited, GS GAMMA Advisors, LLC, and Guggenheim Partners India Management. Securities offered through Guggenheim Funds Distributors, LLC.
© 2020 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.